Wall Street Journal rewards OnControl Bone Marrow System and EZ-IO Intraosseous Infusion System in its 2012 Technology Innovation Awards


On 16 October, the Wall Street Journal announced the winners of its 2012 Technology Innovation Awards. Vidacare Corporation has been recognised for its OnControl Bone Marrow System. OnControl is the overall Bronze winner in this year’s Technology Innovation Awards and the winner of the Medical Devices category. Vidacare’s EZ-IO Intraosseous Infusion System won the overall Gold Technology Innovation of the Year award from the same programme in 2008.

In its twelfth annual competition, the Wall Street Journal received over 500 nominations from around the world, with only seven per cent receiving recognition from the programme.

The OnControl Bone Marrow System combines a specially-designed needle and powered driver to provide the first significant advance in bone marrow biopsy technology in over 40 years. OnControl is proven to offer high quality, safe, reliable and less painful bone marrow procedures, with consistently better samples, benefitting both patients and clinicians.

“The entire team at Vidacare is thrilled to be recognised for a second time by the Wall Street Journal,” said Mark Mellin, president and CEO, Vidacare Corporation. “Our passion is to help patients in need, and this honour is further acknowledgement that we are succeeding in that endeavor.”

Established in 2001, Vidacare Corporation is the pioneer of a broad technology platform for accessing the intraosseous (inside the bone) space. Current products include the EZ-IOIntraosseous Infusion System, the OnControl Bone Marrow System and the OnControl Bone Access System. Applications include vascular access, emergency and disaster medicine, oncology and spinal surgery.